Ads
related to: Pfizer and Vaccine- Schedule A Vaccine
Book A Vaccine Appointment
Today At A Location Near You.
- Take Eligibility Quiz
Check Your Eligibility For Vaccines
That May Help Protect You.
- Pneumococcal Pneumonia
Visit VaxAssist.com To
See If You Are Eligible.
- Questions About Cost?
Visit To Find More Information
On COVID-19 Vaccination Costs.
- Schedule A Vaccine
Search results
Moderna Investors Just Got Some Bullish News
Motley Fool via Yahoo Finance· 11 hours agoFirst, its RSV vaccine wasn't linked to any cases of Guillain-Barré syndrome in late-stage clinical trials (the Pfizer and GSK vaccines
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 5 days agoCAR-T drugs are developed using a patient's own immune cells. Promisingly, Pfizer said in February...
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
Investor's Business Daily· 3 days agoThe shot was also 68.4% effective against acute respiratory disease. William Blair analyst Myles...
Moderna wins FDA approval for RSV vaccine
BioPharma Dive via Yahoo Finance· 3 days agoThe OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.
Is Pfizer the Best Dividend Stock for You?
The Motley Fool via AOL· 3 days agoYou can see below just how big Pfizer got. It's probably time for investors to rip the bandage off on their expectations regarding the pandemic. PFE...
Is Pfizer the Best Dividend Stock for You?
Motley Fool via Yahoo Finance· 3 days agoYou can see below just how big Pfizer got. It's probably time for investors to rip the bandage off on their expectations regarding the pandemic. PFE...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 3 days ago, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving...
Pfizer (PFE) Up 1.8% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 3 days agoNewly acquired product Nurtec ODT/Vydura contributed $178 million in the first quarter, much less...
Is Moderna Stock a Buy Now That It's a 2-Product Company?
Motley Fool via Yahoo Finance· 10 hours agoAbrysvo, another RSV vaccine from Pfizer, also earned approval last May for those 60 or older....
FDA approves Moderna’s mRNA RSV vaccine for older adults
CNN via Yahoo News· 3 days agoThe US Food and Drug Administration has approved another vaccine that can help protect older people...
Ad
related to: Pfizer and Vaccine
